首页 > 最新文献

Metal-Based Drugs最新文献

英文 中文
Synthesis and biological activity of silyl- and germylsubstituted trifluroacetylfurans. 硅基和菌基取代三氟乙酰呋喃的合成及其生物活性。
Pub Date : 2001-01-01 DOI: 10.1155/MBD.2001.211
L Ignatovich, D Zarina, I Shestakova, S Germane, E Lukevics

A series of silyl, germyl and alkyl substituted trifluoroacetylfurans has been synthesized under Friedel-Crafts electrophilic acylation conditions. Biological investigations have demonstrated that germyl derivatives of trifluoroacetylfuran are more toxic than the silicon analogues. 5-Triethylgermyl-2- trifluoroacetylfuran was the most toxic compound (CD(nabla), 11.2 mg kg(-1), i.p. for white mice), 200 times more toxic than the silicon analogue. 5-t-Butyl- and 5-trimethylsilyl-2-trifluroacetylfuran prolong the duration of ethanol anaesthesia by 220 and 140%. 5-Triethylgermyl-2-trifluroacetylfuran exibited high anesthetic activity in hexobarbital test (prolonged the duration by 137%). Some of compounds influenced muscle tone and locomotor coordination parameters. 5-Triethylgermyl-2-trifluomacetylfuran exibited analgesic activity (D(nabla), 0.9 mg k}(-infinity)).

在Friedel-Crafts亲电酰化条件下合成了一系列硅基、香豆基和烷基取代的三氟乙酰呋喃。生物学研究表明,三氟乙酰呋喃的胚芽基衍生物比硅类似物毒性更大。5-三乙基germyl-2-三氟乙酰呋喃是毒性最大的化合物(CD(nabla), 11.2 mg kg(-1),白鼠1 / p),毒性是硅类似物的200倍。5-t-丁基和5-三甲基硅基-2-三氟乙酰呋喃分别使乙醇麻醉的持续时间延长220和140%。5-三乙基germyl-2-三氟乙酰呋喃在六巴比妥试验中表现出较高的麻醉活性(麻醉时间延长137%)。一些化合物影响肌肉张力和运动协调参数。5-三乙基germyl-2-三氟乙酰呋喃表现出镇痛活性(D(nabla), 0.9 mg k}(-infinity))。
{"title":"Synthesis and biological activity of silyl- and germylsubstituted trifluroacetylfurans.","authors":"L Ignatovich,&nbsp;D Zarina,&nbsp;I Shestakova,&nbsp;S Germane,&nbsp;E Lukevics","doi":"10.1155/MBD.2001.211","DOIUrl":"https://doi.org/10.1155/MBD.2001.211","url":null,"abstract":"<p><p>A series of silyl, germyl and alkyl substituted trifluoroacetylfurans has been synthesized under Friedel-Crafts electrophilic acylation conditions. Biological investigations have demonstrated that germyl derivatives of trifluoroacetylfuran are more toxic than the silicon analogues. 5-Triethylgermyl-2- trifluoroacetylfuran was the most toxic compound (CD(nabla), 11.2 mg kg(-1), i.p. for white mice), 200 times more toxic than the silicon analogue. 5-t-Butyl- and 5-trimethylsilyl-2-trifluroacetylfuran prolong the duration of ethanol anaesthesia by 220 and 140%. 5-Triethylgermyl-2-trifluroacetylfuran exibited high anesthetic activity in hexobarbital test (prolonged the duration by 137%). Some of compounds influenced muscle tone and locomotor coordination parameters. 5-Triethylgermyl-2-trifluomacetylfuran exibited analgesic activity (D(nabla), 0.9 mg k}(-infinity)).</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"8 4","pages":"211-4"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2001.211","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27437388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Inhibitory Effects of Dimeric Copper(II) bis(o-acetoxybenzoate) on Platelet-neutrophil adhesion and Thrombosis. 二聚体铜(II)双(邻乙酰氧基苯甲酸酯)对血小板-中性粒细胞粘附和血栓形成的抑制作用。
Pub Date : 2001-01-01 DOI: 10.1155/MBD.2001.103
Z Shen, L Wu, W Liu, J Liu, Z Chen

Antithrombotic effect of the copper-aspirin complex (dimeric copper(II) bis(o-acetoxybenzoate) was evaluated in the model of venous thrombosis; its effects on platelet-neutrophil adhesion were investigated by use of rosette assay. The results showed that the intragastrically administered copper-aspirin complex (5, 7, and 10 mg kg(-1)) dose-dependently lowered the wet and dry thrombus weight; it significantly decreased the binding of arachidonic acid-activated platelets to neutrophils with an IC(50) value of 41.5 mumol L(-1). The results suggested that copper aspirinate inhibited platelet-neutrophil adhesion and resulted in a more potent antithrombotic activity.

在静脉血栓形成模型中评价铜-阿司匹林复合物(二聚体铜(II)双(o-乙酰氧基苯甲酸酯)的抗血栓作用;用玫瑰花结法研究其对血小板-中性粒细胞粘附的影响。结果显示,灌胃铜-阿司匹林复合物(5、7和10 mg kg(-1))剂量依赖性地降低了湿血栓和干血栓的重量;显著降低花生四烯酸活化血小板与中性粒细胞的结合,IC(50)值为41.5 μ mol L(-1)。结果表明,阿斯匹林铜抑制血小板-中性粒细胞粘附,具有更强的抗血栓活性。
{"title":"Inhibitory Effects of Dimeric Copper(II) bis(o-acetoxybenzoate) on Platelet-neutrophil adhesion and Thrombosis.","authors":"Z Shen,&nbsp;L Wu,&nbsp;W Liu,&nbsp;J Liu,&nbsp;Z Chen","doi":"10.1155/MBD.2001.103","DOIUrl":"https://doi.org/10.1155/MBD.2001.103","url":null,"abstract":"<p><p>Antithrombotic effect of the copper-aspirin complex (dimeric copper(II) bis(o-acetoxybenzoate) was evaluated in the model of venous thrombosis; its effects on platelet-neutrophil adhesion were investigated by use of rosette assay. The results showed that the intragastrically administered copper-aspirin complex (5, 7, and 10 mg kg(-1)) dose-dependently lowered the wet and dry thrombus weight; it significantly decreased the binding of arachidonic acid-activated platelets to neutrophils with an IC(50) value of 41.5 mumol L(-1). The results suggested that copper aspirinate inhibited platelet-neutrophil adhesion and resulted in a more potent antithrombotic activity.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"8 2","pages":"103-5"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2001.103","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27438045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Antibacterial Co(II), Cu(II), Ni(II) and Zn(II) Complexes of Thiadiazoles Schiff Bases. 噻二唑Schiff碱的抗菌Co(II)、Cu(II),Ni(II)和Zn(II)配合物。
Pub Date : 2001-01-01 DOI: 10.1155/MBD.2001.95
Z H Chohan, M F Jaffery, C T Supuran

Schiff bases were obtained by condensation of 2-amino-l,3,4-thiadiazole with 5-substituted-salicylaldehydes which were further used to obtain complexes of the type [M(L)(2)]Cl(2), where M=Co(II), Cu(II), Ni(II) or Zn(II). The new compounds described here have been characterized by physical, spectral and analytical data, and have been screened for antibacterial activity against several bacterial strains such as Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. The antibacterial potency of these Schiff bases increased upon chelation/complexation, against the tested bacterial species, opening new aproaches in the fight against antibiotic resistant strains.

席夫碱是由2-氨基- 1,3,4 -噻二唑与5-取代水杨醛缩合而成,并进一步用于得到[M(L)(2)]Cl(2)型配合物,其中M=Co(II), Cu(II), Ni(II)或Zn(II)。本文所描述的新化合物已通过物理、光谱和分析数据进行了表征,并对大肠杆菌、金黄色葡萄球菌和铜绿假单胞菌等几种细菌进行了抗菌活性筛选。这些希夫碱的抗菌效力随着螯合/络合作用的增加而增加,对所测试的细菌物种,在对抗抗生素耐药菌株的斗争中开辟了新的途径。
{"title":"Antibacterial Co(II), Cu(II), Ni(II) and Zn(II) Complexes of Thiadiazoles Schiff Bases.","authors":"Z H Chohan,&nbsp;M F Jaffery,&nbsp;C T Supuran","doi":"10.1155/MBD.2001.95","DOIUrl":"https://doi.org/10.1155/MBD.2001.95","url":null,"abstract":"<p><p>Schiff bases were obtained by condensation of 2-amino-l,3,4-thiadiazole with 5-substituted-salicylaldehydes which were further used to obtain complexes of the type [M(L)(2)]Cl(2), where M=Co(II), Cu(II), Ni(II) or Zn(II). The new compounds described here have been characterized by physical, spectral and analytical data, and have been screened for antibacterial activity against several bacterial strains such as Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. The antibacterial potency of these Schiff bases increased upon chelation/complexation, against the tested bacterial species, opening new aproaches in the fight against antibiotic resistant strains.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"8 2","pages":"95-101"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2001.95","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27438077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 30
Guanine Oxidation in Double-stranded DNA by MnTMPyP/KHSO(5): At Least Three Independent Reaction Pathways. MnTMPyP/KHSO在双链DNA中的鸟嘌呤氧化(5):至少三个独立的反应途径。
Pub Date : 2001-01-01 DOI: 10.1155/MBD.2001.47
A Lapi, G Pratviel, B Meunier

In order to better define the mechanism and the products of guanine oxidation within DNA, we investigated the details of the mechanism of guanine oxidation by a metalloporphyrin, Mn-TMPyP, associated to KHSO(5) on oligonucleotides. We found that the three major products of guanine oxidation are formed by independent reaction routes. The oxidized guanidinohydantoin (1) and the proposed spiro compound 3 derivatives are not precursors of imidazolone lesion (Iz). These guanine lesions as well as their degradation products, may account for non-detected guanine oxidation products on oxidatively damaged DNA.

为了更好地定义DNA内鸟嘌呤氧化的机制和产物,我们研究了寡核苷酸上与KHSO(5)相关的金属卟啉Mn-TMPyP氧化鸟嘌呤的机制细节。我们发现鸟嘌呤氧化的三个主要产物是通过独立的反应途径形成的。氧化的胍醛酸钠(1)和提出的螺旋化合物3衍生物不是咪唑酮病变(Iz)的前体。这些鸟嘌呤损伤及其降解产物可能解释了氧化损伤DNA上未检测到的鸟嘌呤氧化产物。
{"title":"Guanine Oxidation in Double-stranded DNA by MnTMPyP/KHSO(5): At Least Three Independent Reaction Pathways.","authors":"A Lapi,&nbsp;G Pratviel,&nbsp;B Meunier","doi":"10.1155/MBD.2001.47","DOIUrl":"https://doi.org/10.1155/MBD.2001.47","url":null,"abstract":"<p><p>In order to better define the mechanism and the products of guanine oxidation within DNA, we investigated the details of the mechanism of guanine oxidation by a metalloporphyrin, Mn-TMPyP, associated to KHSO(5) on oligonucleotides. We found that the three major products of guanine oxidation are formed by independent reaction routes. The oxidized guanidinohydantoin (1) and the proposed spiro compound 3 derivatives are not precursors of imidazolone lesion (Iz). These guanine lesions as well as their degradation products, may account for non-detected guanine oxidation products on oxidatively damaged DNA.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"8 1","pages":"47-56"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2001.47","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27438071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Pharmacological Effects of the Ruthenium Complex NAMI-A Given Orally to CBA Mice With MCa Mammary Carcinoma. 口服钌复合物NAMI-A对CBA小鼠MCa乳腺癌的药理作用。
Pub Date : 2001-01-01 DOI: 10.1155/MBD.2001.1
S Zorzet, A Sorc, C Casarsa, M Cocchietto, G Sava

NAMI-A, imidazolium trans-imidazoledimethylsulfoxidetetrachlororuthenate, is a ruthenium based compounds capable of inhibiting the growth of lung metastases of solid tumours in a number of experimental conditions.The aim of this study was to investigate the potential use of NAMI-A by the oral route to treat lung metastases of MCa mammary carcinoma in the CBA mouse. treatment of mice, carrying intramuscular tumours in advanced stage of growth, for 11 consecutive days caused a significant reduction of the weight of lung metastases over the range of doses from 150 to 600 mg/kg/day. No sign of toxicity was observed at the histological analysis in the gut epithelium or in the kidney parenchyma, and NAMI-A concentration in the kidney was more than 10-fold lower than after intraperitoneal treatments. NAMI-A is thus active against metastases also by the oral route, suggesting the use of this way to treat tumour bearing hosts for long periods.

NAMI-A,咪唑反式咪唑二甲基亚砜四氯膦酸盐,是一种钌基化合物,能够在许多实验条件下抑制实体瘤肺转移的生长。本研究的目的是探讨口服NAMI-A治疗CBA小鼠MCa乳腺癌肺转移的潜在应用。在150至600 mg/kg/天的剂量范围内,连续11天治疗生长晚期肌肉内肿瘤的小鼠,可显著减少肺转移灶的重量。在肠上皮和肾实质的组织学分析中未观察到毒性迹象,肾脏中的NAMI-A浓度比腹腔注射后降低了10倍以上。因此,NAMI-A也通过口服途径对转移有活性,这表明这种方法可以长期治疗肿瘤宿主。
{"title":"Pharmacological Effects of the Ruthenium Complex NAMI-A Given Orally to CBA Mice With MCa Mammary Carcinoma.","authors":"S Zorzet,&nbsp;A Sorc,&nbsp;C Casarsa,&nbsp;M Cocchietto,&nbsp;G Sava","doi":"10.1155/MBD.2001.1","DOIUrl":"https://doi.org/10.1155/MBD.2001.1","url":null,"abstract":"<p><p>NAMI-A, imidazolium trans-imidazoledimethylsulfoxidetetrachlororuthenate, is a ruthenium based compounds capable of inhibiting the growth of lung metastases of solid tumours in a number of experimental conditions.The aim of this study was to investigate the potential use of NAMI-A by the oral route to treat lung metastases of MCa mammary carcinoma in the CBA mouse. treatment of mice, carrying intramuscular tumours in advanced stage of growth, for 11 consecutive days caused a significant reduction of the weight of lung metastases over the range of doses from 150 to 600 mg/kg/day. No sign of toxicity was observed at the histological analysis in the gut epithelium or in the kidney parenchyma, and NAMI-A concentration in the kidney was more than 10-fold lower than after intraperitoneal treatments. NAMI-A is thus active against metastases also by the oral route, suggesting the use of this way to treat tumour bearing hosts for long periods.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"8 1","pages":"1-7"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2001.1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27438066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 38
Transition Metal Ion Complexes of Schiff-bases. Synthesis, Characterization and Antibacterial Properties. 席夫碱的过渡金属离子配合物。合成、表征及抗菌性能研究
Pub Date : 2001-01-01 DOI: 10.1155/MBD.2001.137
Z H Chohan, A Munawar, C T Supuran

Some novel transition metal [Co(II), Cu(II), Ni(II) and Zn(II)] complexes of substituted pyridine Schiff-bases have been prepared and characterized by physical, spectral and analytical data. The synthesized Schiff-bases act as deprotonated tridentate for the complexation reaction with Co(II), Ni(II) and Zn(II) ions. The new compounds, possessing the general formula [M(L)(2)] where [M=Co(II), Cu(II), Ni(II) and Zn(II) and HL=HL(1), HL(2), HL(3) and HL(4)] show an octahedral geometry. In order to evaluate the effect of metal ions upon chelation, the Schiff bases and their complexes have been screened for antibacterial activity against the strains such as Escherichia coli,Staphylococcus aureus, and Pseudomonas aeruginosa. The complexed Schiff bases have shown to be more antibacterial against one more bacterial species as compared to uncomplexed Schiff-bases.

本文制备了几种新型的取代吡啶席夫碱过渡金属[Co(II), Cu(II), Ni(II)和Zn(II)]配合物,并用物理、光谱和分析数据对其进行了表征。合成的席夫碱与Co(II)、Ni(II)和Zn(II)离子进行去质子化络合反应。新化合物具有通式[M(L)(2)],其中[M=Co(II), Cu(II), Ni(II)和Zn(II), HL=HL(1), HL(2), HL(3)和HL(4)]为八面体结构。为了评价金属离子对螯合作用的影响,对希夫碱及其配合物进行了抑菌活性筛选,对大肠杆菌、金黄色葡萄球菌、铜绿假单胞菌等菌株进行了抑菌活性研究。与未络合的席夫碱相比,络合的席夫碱对一种以上的细菌具有更强的抗菌作用。
{"title":"Transition Metal Ion Complexes of Schiff-bases. Synthesis, Characterization and Antibacterial Properties.","authors":"Z H Chohan,&nbsp;A Munawar,&nbsp;C T Supuran","doi":"10.1155/MBD.2001.137","DOIUrl":"https://doi.org/10.1155/MBD.2001.137","url":null,"abstract":"<p><p>Some novel transition metal [Co(II), Cu(II), Ni(II) and Zn(II)] complexes of substituted pyridine Schiff-bases have been prepared and characterized by physical, spectral and analytical data. The synthesized Schiff-bases act as deprotonated tridentate for the complexation reaction with Co(II), Ni(II) and Zn(II) ions. The new compounds, possessing the general formula [M(L)(2)] where [M=Co(II), Cu(II), Ni(II) and Zn(II) and HL=HL(1), HL(2), HL(3) and HL(4)] show an octahedral geometry. In order to evaluate the effect of metal ions upon chelation, the Schiff bases and their complexes have been screened for antibacterial activity against the strains such as Escherichia coli,Staphylococcus aureus, and Pseudomonas aeruginosa. The complexed Schiff bases have shown to be more antibacterial against one more bacterial species as compared to uncomplexed Schiff-bases.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"8 3","pages":"137-43"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2001.137","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27438050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 120
Novel Unsymmetrical Ru(III) and Mixed-valence Ru(III)/Ru(II) Dinuclear Compounds Related to the Antimetastatic Ru(III) Drug NAMI-A. 与抗转移Ru(III)药物NAMI-A相关的新型不对称Ru(III)和混价Ru(III)/Ru(II)双核化合物。
Pub Date : 2001-01-01 DOI: 10.1155/MBD.2001.9
B Serli, E Iengo, T Gianferrara, E Zangrando, E Alessio

In this paper we report the stepwise preparation and the characterization of new unsymmetrical monoanionic Ru(III) dinuclear compounds, [NH(4)][{trans-RuCl(4)(Me(2)SO-S)}(mu-L){mer-RuCl(3)(Me(2)SO-S)(Me(2)SO-O)}] (L = pyz (1), pym (2)). By a similar synthetic approach we also prepared new mixed-valence Ru(III)/Ru(II) dinuclear compounds of formula [NH(4)][{trans-RuCl(4)(Me(2)SO-S)}(mu-pyz){cis,cis,cis-RuCl(2)(Me(2)SO-S)(2)(CO)}] (L = pyrazine (pyz, 3), pyrimidine (pym, 4)). Moreover, we describe the chemical behavior of compounds 1-4 in physiological solution, also after complete reduction (with ascorbic acid) to the corresponding Ru(II)/Ru(II) species. Overall, the chemical behavior of 1 and 2 after reduction resembles that of the corresponding dianionic and neutral dinuclear species, [{trans-RuCl(3)(Me(2)SO-S)}(2)(mu-L)](2-)and [{mer-RuCl(3)(Me(2)SO-S)(Me(2)SO-O)}(2) (mu-L)]. On the other hand, the mixed-valence dinuclear compounds 3 and 4, owing to the great inertness of the cis,cis,cis-RuCl(2)(Me(2)SO-S)(2)(CO)(1/2mu-L) fragment, behave substantially like the mononuclear species [trans-RuCl(4)(Me(2)SO-S)(L)](-) in which the terminally bonded L ligand can be considered as bearing a bulky substituent on the other N atom.

本文报道了新型不对称单阴离子Ru(III)双核化合物[nh4) [{trans-RuCl(4)(Me(2)SO-S)}(mu-L){mer-RuCl(3)(Me(2)SO-S)(Me(2)SO-O)}] (L = pyz (1), pym(2))的逐步制备和表征。通过类似的合成方法,我们还制备了新的混合价Ru(III)/Ru(II)双核化合物,分子式为[nh4)][{trans-RuCl(4)(Me(2)SO-S)}(mu-pyz){顺式,顺式,顺式- rucl (2)(Me(2)SO-S)(2)(CO)}] (L =吡嗪(pyz, 3),嘧啶(pym, 4))。此外,我们描述了化合物1-4在生理溶液中的化学行为,以及在(用抗坏血酸)完全还原成相应的Ru(II)/Ru(II)物质后的化学行为。总的来说,1和2在还原后的化学行为与相应的重阴离子和中性双核物质[{trans-RuCl(3)(Me(2)SO-S)}(2)(mu-L)](2-)和[{mer-RuCl(3)(Me(2)SO-S)(Me(2)SO-O)}(2) (mu-L)]相似。另一方面,混合价双核化合物3和4,由于顺、顺、顺式- rucl (2)(Me(2)SO-S)(2)(CO)(1/2mu-L)的极大惰性,其行为基本上类似于单核物质[trans-RuCl(4)(Me(2)SO-S)(L)](-),其中末端键合的L配体可以认为在另一个N原子上承载了一个大的取代基。
{"title":"Novel Unsymmetrical Ru(III) and Mixed-valence Ru(III)/Ru(II) Dinuclear Compounds Related to the Antimetastatic Ru(III) Drug NAMI-A.","authors":"B Serli,&nbsp;E Iengo,&nbsp;T Gianferrara,&nbsp;E Zangrando,&nbsp;E Alessio","doi":"10.1155/MBD.2001.9","DOIUrl":"https://doi.org/10.1155/MBD.2001.9","url":null,"abstract":"<p><p>In this paper we report the stepwise preparation and the characterization of new unsymmetrical monoanionic Ru(III) dinuclear compounds, [NH(4)][{trans-RuCl(4)(Me(2)SO-S)}(mu-L){mer-RuCl(3)(Me(2)SO-S)(Me(2)SO-O)}] (L = pyz (1), pym (2)). By a similar synthetic approach we also prepared new mixed-valence Ru(III)/Ru(II) dinuclear compounds of formula [NH(4)][{trans-RuCl(4)(Me(2)SO-S)}(mu-pyz){cis,cis,cis-RuCl(2)(Me(2)SO-S)(2)(CO)}] (L = pyrazine (pyz, 3), pyrimidine (pym, 4)). Moreover, we describe the chemical behavior of compounds 1-4 in physiological solution, also after complete reduction (with ascorbic acid) to the corresponding Ru(II)/Ru(II) species. Overall, the chemical behavior of 1 and 2 after reduction resembles that of the corresponding dianionic and neutral dinuclear species, [{trans-RuCl(3)(Me(2)SO-S)}(2)(mu-L)](2-)and [{mer-RuCl(3)(Me(2)SO-S)(Me(2)SO-O)}(2) (mu-L)]. On the other hand, the mixed-valence dinuclear compounds 3 and 4, owing to the great inertness of the cis,cis,cis-RuCl(2)(Me(2)SO-S)(2)(CO)(1/2mu-L) fragment, behave substantially like the mononuclear species [trans-RuCl(4)(Me(2)SO-S)(L)](-) in which the terminally bonded L ligand can be considered as bearing a bulky substituent on the other N atom.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"8 1","pages":"9-18"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2001.9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27438067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Oligonucleotides modified with transplatin derivatives: fast and efficient metalloribozymes. 用移植衍生物修饰的寡核苷酸:快速高效的金属酶。
Pub Date : 2001-01-01 DOI: 10.1155/MBD.2001.39
R Dalbiès-Tran, M Leng, M Boudvillain

When an oligonucleotide containing a 1,3-(G,G)-transplatin cross-link at a GNG site (N represents a C, T, A or U residue) is paired with its complementary strand, the intrastrand adduct rearranges into an interstrand cross-link, resulting in the covalent attachment of both strands. Here, we have studied the influence of the inert ligands of the platinum(II) complex and of the nucleotide residues in the vicinity of the adduct on the rearrangement reaction. Dramatic effects on the linkage isomerization rate could be 37. The results are analyzed in relation with the mechanism of rearrangement of the 1,3-intrastrand adducts into interstrand cross-links. The relevance of platinated oligonucleotides as potent and specific drugs is discussed.

当在GNG位点(N代表C、T、a或U残基)上含有1,3-(G,G)-移植交联的寡核苷酸与其互补链配对时,链内加合物重新排列成链间交联,导致两条链的共价附着。在这里,我们研究了铂(II)配合物的惰性配体和加合物附近的核苷酸残基对重排反应的影响。对连锁异构化速率的显著影响可能是37。分析了1,3-链内加合物重排成链间交联的机理。本文讨论了铂化寡核苷酸作为强效和特异性药物的相关性。
{"title":"Oligonucleotides modified with transplatin derivatives: fast and efficient metalloribozymes.","authors":"R Dalbiès-Tran,&nbsp;M Leng,&nbsp;M Boudvillain","doi":"10.1155/MBD.2001.39","DOIUrl":"https://doi.org/10.1155/MBD.2001.39","url":null,"abstract":"<p><p>When an oligonucleotide containing a 1,3-(G,G)-transplatin cross-link at a GNG site (N represents a C, T, A or U residue) is paired with its complementary strand, the intrastrand adduct rearranges into an interstrand cross-link, resulting in the covalent attachment of both strands. Here, we have studied the influence of the inert ligands of the platinum(II) complex and of the nucleotide residues in the vicinity of the adduct on the rearrangement reaction. Dramatic effects on the linkage isomerization rate could be 37. The results are analyzed in relation with the mechanism of rearrangement of the 1,3-intrastrand adducts into interstrand cross-links. The relevance of platinated oligonucleotides as potent and specific drugs is discussed.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"8 1","pages":"39-45"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2001.39","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27438070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Essential metalloelement chelates facilitate repair of radiation injury. 必需金属元素螯合物促进辐射损伤的修复。
Pub Date : 2001-01-01 DOI: 10.1155/MBD.2001.215
J R Sorenson, L S Soderberg, L W Chang, R B Walker

Treatment with essential metalloelement (Cu, Fe, Mn, and Zn) chelates or combinations of them before and/or after radiation injury is a useful approach to overcoming radiation injury. No other agents are known to increase survival when they are used to treat after irradiation, in a radiorecovery treatment paradigm. These chelates may be useful in facilitating de novo syntheses of essential metalloelement-dependent enzymes required to repair radiation injury. Reports of radioprotection, which involves treatment before irradiation, with calcium-channel blockers, acyl Melatonin homologs, and substituted anilines, which may serve as chelating agents after biochemical modification in vivo, as well as Curcumin, which is a chelating agent, have been included in this review. These inclusions are intended to suggest additional approaches to combination treatments that may be useful in facilitating radiation recovery. These approaches to radioprotection and radiorecovery offer promise in facilitating recovery from radiation-induced injury experienced by patients undergoing radiotherapy for neoplastic disease and by individuals who experience environmental, occupational, or accidental exposure to ultraviolet, x-ray, or gamma-ray radiation. Since there are no existing treatments of radiation-injury intended to facilitate tissue repair, studies of essential metalloelement chelates and combinations of them, as well as combinations of them with existing organic radioprotectants, seem worthwhile.

在辐射损伤前后用必需金属元素(Cu、Fe、Mn和Zn)螯合物或它们的组合治疗是克服辐射损伤的有效方法。在放射恢复治疗范式中,没有其他药物用于照射后治疗时已知能增加生存率。这些螯合物可能有助于促进修复辐射损伤所需的必需金属元素依赖酶的重新合成。关于辐射防护的报道,包括在辐照前使用钙通道阻滞剂、酰基褪黑素同系物、在体内生化修饰后可作为螯合剂的取代苯胺,以及姜黄素,这是一种螯合剂。这些内容旨在建议联合治疗的其他方法,这些方法可能有助于促进放射恢复。这些放射防护和放射恢复方法有望促进因肿瘤疾病接受放射治疗的患者以及经历环境、职业或意外暴露于紫外线、x射线或伽马射线辐射的个人从辐射引起的损伤中恢复。由于目前还没有旨在促进组织修复的辐射损伤治疗方法,研究必需金属元素螯合物及其组合,以及它们与现有有机放射保护剂的组合,似乎是值得的。
{"title":"Essential metalloelement chelates facilitate repair of radiation injury.","authors":"J R Sorenson,&nbsp;L S Soderberg,&nbsp;L W Chang,&nbsp;R B Walker","doi":"10.1155/MBD.2001.215","DOIUrl":"https://doi.org/10.1155/MBD.2001.215","url":null,"abstract":"<p><p>Treatment with essential metalloelement (Cu, Fe, Mn, and Zn) chelates or combinations of them before and/or after radiation injury is a useful approach to overcoming radiation injury. No other agents are known to increase survival when they are used to treat after irradiation, in a radiorecovery treatment paradigm. These chelates may be useful in facilitating de novo syntheses of essential metalloelement-dependent enzymes required to repair radiation injury. Reports of radioprotection, which involves treatment before irradiation, with calcium-channel blockers, acyl Melatonin homologs, and substituted anilines, which may serve as chelating agents after biochemical modification in vivo, as well as Curcumin, which is a chelating agent, have been included in this review. These inclusions are intended to suggest additional approaches to combination treatments that may be useful in facilitating radiation recovery. These approaches to radioprotection and radiorecovery offer promise in facilitating recovery from radiation-induced injury experienced by patients undergoing radiotherapy for neoplastic disease and by individuals who experience environmental, occupational, or accidental exposure to ultraviolet, x-ray, or gamma-ray radiation. Since there are no existing treatments of radiation-injury intended to facilitate tissue repair, studies of essential metalloelement chelates and combinations of them, as well as combinations of them with existing organic radioprotectants, seem worthwhile.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"8 4","pages":"215-34"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2001.215","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27437389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Construction of Ru(II) Polypyridyl Based Macrocycles: Synthesis, Characterization, Electrochemical, Li Binding, Antitumour and Anti-HIV properties. Ru(II)多吡啶基大环的构建:合成、表征、电化学、锂结合、抗肿瘤和抗hiv特性。
Pub Date : 2001-01-01 DOI: 10.1155/MBD.2001.113
L Mishra, R Sinha, P C Pandey

Some ruthenium (II) polypyridyl complexes with a bis-chalcone (obtained by the condensation of 3-methyl-thiophene-2-carboxaldehyde and 4-acetyl pyridine) have been synthesized and characterized spectroscopically (IR, NMR, UV/Vis), conductimetric, elemental analysis and FAB mass data. Their luminescent, redox and Li(+) binding properties have been studied. The anti-HIV and antitumour activities have also been reported.

合成了一些钌(II)多吡啶配合物(由3-甲基-噻吩-2-甲醛和4-乙酰吡啶缩合而成),并对其进行了光谱(IR、NMR、UV/Vis)、电导、元素分析和FAB质量数据表征。研究了它们的发光、氧化还原和Li(+)结合性能。抗艾滋病毒和抗肿瘤活性也有报道。
{"title":"Construction of Ru(II) Polypyridyl Based Macrocycles: Synthesis, Characterization, Electrochemical, Li Binding, Antitumour and Anti-HIV properties.","authors":"L Mishra,&nbsp;R Sinha,&nbsp;P C Pandey","doi":"10.1155/MBD.2001.113","DOIUrl":"https://doi.org/10.1155/MBD.2001.113","url":null,"abstract":"<p><p>Some ruthenium (II) polypyridyl complexes with a bis-chalcone (obtained by the condensation of 3-methyl-thiophene-2-carboxaldehyde and 4-acetyl pyridine) have been synthesized and characterized spectroscopically (IR, NMR, UV/Vis), conductimetric, elemental analysis and FAB mass data. Their luminescent, redox and Li(+) binding properties have been studied. The anti-HIV and antitumour activities have also been reported.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"8 2","pages":"113-7"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2001.113","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27438047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
Metal-Based Drugs
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1